siRNA-mediated knockdown of GLIPR1 resulted in a 10–22% decrease in proliferation in melanoma cells compared to 31 and 25% decrease for U251 and SNB75 glioma cells respectively, 4 days after transfection (Figure 3D). The gene discussed is GLIPR1; the disease is central nervous system cancer.